Focused on dermatology therapeutics, the biopharmaceutical firm developed prescription treatments for skin diseases including atopic dermatitis and primary axillary hyperhidrosis. Its pipeline and commercial portfolio centered on specialty dermatology, with revenue and valuation historically tied to...
1 member of Congress has disclosed 7 trades in Dermira Inc (DERM), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-05-24 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2017-08-24 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-08-23 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-11-15 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-04-14 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2011-08-08 | MICHAEL T. MCCAUL | buy | $15K – $50K |
| 2011-02-12 | MICHAEL T. MCCAUL | buy | $15K – $50K |